News

For 20 years, the brain and its diseases have been researched at the Tübingen Hertie Institute for Clinical Brain Research (HIH). The aim is to enable…

Millions of people worldwide suffer from Alzheimer's dementia - and the number is growing steadily. Their fear of losing their own self is big. The…

A conversation with Professors Johannes Dichgans and Hans-Jochen Heinze about the beginnings of the Center for Neurology in Tübingen, its model…

At the HIH, as part of the Johannes Dichgans scholarship program, doctoral scholarships for students of human medicine will again be offered for the…

Dr. Isabel Gugel is the first (neuro)surgeon to be accepted into the “Margarete von Wrangell” program. The fellowship allows her to further build up…

They could partially replace the current standard method and potentially revolutionize muscle diagnostics. Unclear muscle weakness, paralysis, cramps,…

Our brain processes facial expressions independently of the face shape - which allows us to even understand the emotions of fantasy figures like…

Last Monday, the U.S. Food and Drug Administration (FDA) approved the Alzheimer's drug aducanumab, using its "accelerated approval" program. Prof. Dr.…

Prof. Dr. Dr. Ghazaleh Tabatabai talks about the state of research and treatment options for brain tumors in with the Hertie Foundation (interview in…

The ability to correctly estimate quantities improves with the number of hours of videoplay per week, reports a research team lead by Professor Dr.…